Showing 1 - 10 of 7,628
Persistent link: https://www.econbiz.de/10014282191
Persistent link: https://www.econbiz.de/10012433661
Persistent link: https://www.econbiz.de/10012390362
Persistent link: https://www.econbiz.de/10013164549
segment of the pharmaceutical industry. The Biological Price Competition and Innovation Act (BPCIA) of 2010 created an …
Persistent link: https://www.econbiz.de/10012496071
innovation with timely generic market entry. An examination of the inefficiencies created by the Canadian regulations reveals …
Persistent link: https://www.econbiz.de/10013074086
A decade ago, Canadian Government scientists invented a vaccine against Ebola virus (VSV-ZEBOV). 1 That vaccine is based on a live attenuated vesicular stomatitis virus, and has several known advantages over the other vaccine candidates in clinical trials: first, in animals one inoculation...
Persistent link: https://www.econbiz.de/10012996765
inventions by Canada in the area of pharmaceuticals under the relevant provisions of the Canadian implementing legislation, in …
Persistent link: https://www.econbiz.de/10012884077
The Canadian experience could be of interest to large developing countries with significant generic manufacturing capacities, foreign investment in the pharmaceutical sector, modest private investment in drug discovery, numerous international IP obligations and constant pressure from the US....
Persistent link: https://www.econbiz.de/10014196788